masterThesis
Uso de medicamentos e prolongamento do intervalo QTc em uma Unidade de Terapia Intensiva adulto
Fecha
2017-05-31Registro en:
FERNANDES, Flávia Evelyn Medeiros. Uso de medicamentos e prolongamento do intervalo QTc em uma Unidade de Terapia Intensiva adulto. 2017. 143f. Dissertação (Mestrado em Ciências Farmacêuticas) - Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, 2017.
Autor
Fernandes, Flávia Evelyn Medeiros
Resumen
Introduction: Medication-induced long QT syndrome (LQTS) can lead to Torsade de Pointes (TdP), a rare polymorphic ventricular tachycardia that can be fatal. Objectives: To investigate the QTc interval prolongation in patients admitted to the General Intensive Care Unit (ICU) in terms of prevalence, degree of association with medications administered and drug interactions, time evolution and relation to clinical outcomes. Methods: Approved by the Research Ethics Committee in accordance with opinion No. 666,969. Observational, prospective and cross-sectional study, conducted between May 2014 and July 2016 at the ICU of the University Hospital Onofre Lopes. The admitted patients were investigated for the presence of QT prolongation at admission via the electrocardiogram in a case-control study. Correction of the QT interval by heart rate (QTc) was performed using the Bazzet formula. All patients were observed until discharge from the ICU (prospective analytical cohort phase) for cardiac arrest or death events, and those with LQTS were observed for 48 hours and at discharge for reassessment of the QTc interval. Difference from the QTc to the initial value was analyzed by covariance. For the determination of the risk of QTc prolongation associated with each medication, logistic regression was used. The comparison between patients with and without LQTS from time to cardiac arrest or death was analyzed with the logrank test and logistic regression. The risk of these events was estimated by Kaplan-Meier. Results: A prevalence of 34% (249/734) of LQTS was identified in which 13.3% (33/249) had QTc greater than 500 ms. Amiodarone (OR 2.434, p = 0.02) and haloperidol (OR 3.333, p = 0.02) were associated with LQTS, as well as medicines not yet described in the literature: sufentanil (OR 3.667, p <0.01), clopidogrel (1,894, p = (OR 1.174, p = 0.01), or cephalosporin (OR 1.575, p = 0.04), noradrenaline (OR 1,701, p = 0.01), nitroglycerin (OR 1,904, p = 0.01), cefazolin ) And protamine (OR 5,952, p <0.01). The presence of drug interaction increased the QTc interval by 16.8 ms (95% CI 4.6 to 29.0 ms, p <0.01), and the pharmacodynamic type was associated with an increase of 27.6 ms (95% CI 2.1 to 53.2 ms , P = 0.03). In patients who were prescribed drugs associated with LQTS, the difference in QTc in 48 hours for the initial value was 15.8 ms (95% CI -9.9 to 41.4 ms) higher than in the non-medication group (P = 0.22). Of the patients with LQTS at admission, 39% presented it after 48 hours and 40% at discharge. A 3-fold higher risk of cardiac arrest was observed in patients with LQTS (OR 3.030, p = 0.02), whereas no significant difference in risk of death was observed (rank p = 0.87). Conclusions: There was a high prevalence of LQTS in critically ill patients. Drugs not yet described were identified as possible inducers of LQTS. It was observed that the use of drugs did not significantly affect the QTc interval, but that the drug interactions increased the QTc interval, with only those of the pharmacodynamic type being highlighted. There was an increased risk of cardiac arrest between the long QTc group, but no difference in mortality.